Maximising Congress Impact in Pharma

THE CONTENT

A congress is not just a three-day event.

It is one of the most significant (and potentially most impactful) engagement investments pharmaceutical companies make.

Yet despite the scale of this investment, many congresses still behave like fireworks: bright, intense, short-lived, and quickly forgotten once the booth is dismantled.

This happens because congress execution is often designed around pharma activity rather than around the deeper needs of healthcare professionals. HCPs do not attend congresses to meet pharma. They attend to make sense of emerging science, validate their thinking with peers, and build confidence in their clinical decisions.

This course addresses that gap.

Participants learn how to define and report on objectives, design congress journeys that create measurable, sustained HCP impact before, during, and after the event, and embed structured lessons learned and handovers so that each congress improves the next rather than starting from scratch.

THE EXPERT

Yacin Marzouki, CEO, Biondhealth